These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 7542899

  • 1. Systemic administration of rhIGF-I or rhIGF-I/IGFBP-3 increases cortical bone and lean body mass in ovariectomized rats.
    Bagi CM, DeLeon E, Brommage R, Adams S, Rosen D, Sommer A.
    Bone; 1995 Apr; 16(4 Suppl):263S-269S. PubMed ID: 7542899
    [Abstract] [Full Text] [Related]

  • 2. The effect of systemically administered rhIGF-I/IGFBP-3 complex on cortical bone strength and structure in ovariectomized rats.
    Bagi C, van der Meulen M, Brommage R, Rosen D, Sommer A.
    Bone; 1995 May; 16(5):559-65. PubMed ID: 7544602
    [Abstract] [Full Text] [Related]

  • 3. Treatment of ovariectomized rats with the complex of rhIGF-I/IGFBP-3 increases cortical and cancellous bone mass and improves structure in the femoral neck.
    Bagi CM, DeLeon E, Brommage R, Rosen D, Sommer A.
    Calcif Tissue Int; 1995 Jul; 57(1):40-6. PubMed ID: 7545533
    [Abstract] [Full Text] [Related]

  • 4. The effects of recombinant human insulin-like growth factor (rhIGF)-1 and rhIGF-1/IGF binding protein-3 administration on rat osteopenia induced by ovariectomy with concomitant bilateral sciatic neurectomy.
    Narusawa K, Nakamura T, Suzuki K, Matsuoka Y, Lee LJ, Tanaka H, Seino Y.
    J Bone Miner Res; 1995 Dec; 10(12):1853-64. PubMed ID: 8619365
    [Abstract] [Full Text] [Related]

  • 5. Benefit of systemically administered rhIGF-I and rhIGF-I/IGFBP-3 on cancellous bone in ovariectomized rats.
    Bagi CM, Brommage R, Deleon L, Adams S, Rosen D, Sommer A.
    J Bone Miner Res; 1994 Aug; 9(8):1301-12. PubMed ID: 7526611
    [Abstract] [Full Text] [Related]

  • 6. The complex of recombinant human insulin-like growth factor-I (rhIGF-I) and its binding protein-5 (IGFBP-5) induces local bone formation in murine calvariae and in rat cortical bone after local or systemic administration.
    Bauss F, Lang K, Dony C, Kling L.
    Growth Horm IGF Res; 2001 Feb; 11(1):1-9. PubMed ID: 11437468
    [Abstract] [Full Text] [Related]

  • 7. Effects of short-term recombinant human insulin-like growth factor I administration on bone turnover in osteopenic women with anorexia nervosa.
    Grinspoon S, Baum H, Lee K, Anderson E, Herzog D, Klibanski A.
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3864-70. PubMed ID: 8923830
    [Abstract] [Full Text] [Related]

  • 8. Prostaglandin E2 increased rat cortical bone mass when administered immediately following ovariectomy.
    Ke HZ, Jee WS, Zeng QQ, Li M, Lin BY.
    Bone Miner; 1993 Jun; 21(3):189-201. PubMed ID: 8400919
    [Abstract] [Full Text] [Related]

  • 9. Effects of recombinant human growth hormone and insulin-like growth factor-I, with or without 17 beta-estradiol, on bone and mineral homeostasis of aged ovariectomized rats.
    Verhaeghe J, van Bree R, Van Herck E, Thomas H, Skottner A, Dequeker J, Mosekilde L, Einhorn TA, Bouillon R.
    J Bone Miner Res; 1996 Nov; 11(11):1723-35. PubMed ID: 8915780
    [Abstract] [Full Text] [Related]

  • 10. Lack of an effect of sodium zeolite A on rat tibia histomorphometry.
    Firling CE, Evans GL, Wakley GK, Sibonga J, Turner RT.
    J Bone Miner Res; 1996 Feb; 11(2):254-63. PubMed ID: 8822350
    [Abstract] [Full Text] [Related]

  • 11. Recombinant human insulin-like growth factor (IGF)-binding protein-1 inhibits somatic growth stimulated by IGF-I and growth hormone in hypophysectomized rats.
    Cox GN, McDermott MJ, Merkel E, Stroh CA, Ko SC, Squires CH, Gleason TM, Russell D.
    Endocrinology; 1994 Nov; 135(5):1913-20. PubMed ID: 7525258
    [Abstract] [Full Text] [Related]

  • 12. A comparative study of the bone metabolic response to dried plum supplementation and PTH treatment in adult, osteopenic ovariectomized rat.
    Smith BJ, Bu SY, Wang Y, Rendina E, Lim YF, Marlow D, Clarke SL, Cullen DM, Lucas EA.
    Bone; 2014 Jan; 58():151-9. PubMed ID: 24125756
    [Abstract] [Full Text] [Related]

  • 13. Recombinant human insulin-like growth factor binding protein-3 (rhIGFBP-3): effects on the glycemic and growth promoting activities of rhIGF-1 in the rat.
    Clark RG, Mortensen D, Reifsynder D, Mohler M, Etcheverry T, Mukku V.
    Growth Regul; 1993 Mar; 3(1):50-2. PubMed ID: 7683530
    [Abstract] [Full Text] [Related]

  • 14. Effects of growth hormone and low dose estrogen on bone growth and turnover in long bones of hypophysectomized rats.
    Kidder LS, Schmidt IU, Evans GL, Turner RT.
    Calcif Tissue Int; 1997 Oct; 61(4):327-35. PubMed ID: 9312204
    [Abstract] [Full Text] [Related]

  • 15. Response of cortical bone to antiresorptive agents and parathyroid hormone in aged ovariectomized rats.
    Baumann BD, Wronski TJ.
    Bone; 1995 Feb; 16(2):247-53. PubMed ID: 7756054
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Parathyroid hormone restores bone mass and enhances osteoblast insulin-like growth factor I gene expression in ovariectomized rats.
    Watson P, Lazowski D, Han V, Fraher L, Steer B, Hodsman A.
    Bone; 1995 Mar; 16(3):357-65. PubMed ID: 7786639
    [Abstract] [Full Text] [Related]

  • 19. Short-term systemic insulin-like growth factor-1 is unable to prevent cyclosporin A-induced osteopenia in the rat.
    Mann GN, Sass DA, Chen HK, Buchinsky FJ, Bryer HP, Ma YF, Jee WS, Rucinski B, Epstein S.
    Calcif Tissue Int; 1996 Jul; 59(1):38-44. PubMed ID: 8661983
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.